FDAnews Drug Daily Bulletin

ENANTA PHARMACEUTICALS ACHIEVES MILESTONE IN ALLIANCE WITH SHIONOGI & CO., LTD.

Dec. 21, 2005
A A

Enanta Pharmaceuticals today announced that it has received a milestone payment from its East Asia development and commercialization partner, Shionogi & Co., Ltd., as Phase 2 studies have initiated in Japan for its community antibiotic, EDP-420 (formerly known as EP-013420, and known in Japan as S-013420).

Yahoo News (http://biz.yahoo.com/prnews/051220/netu018.html?.v=39)